Sendero Wealth Management LLC Acquires 978 Shares of Humana Inc. $HUM

Sendero Wealth Management LLC increased its holdings in shares of Humana Inc. (NYSE:HUM) by 28.2% in the second quarter, Holdings Channel.com reports. The firm owned 4,440 shares of the insurance provider’s stock after purchasing an additional 978 shares during the quarter. Sendero Wealth Management LLC’s holdings in Humana were worth $1,085,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of HUM. Janney Montgomery Scott LLC bought a new position in shares of Humana during the first quarter worth about $1,309,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in shares of Humana by 16.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider’s stock worth $300,728,000 after acquiring an additional 158,528 shares in the last quarter. Focus Partners Wealth raised its holdings in shares of Humana by 104.2% in the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider’s stock valued at $1,701,000 after purchasing an additional 3,281 shares during the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of Humana by 2.4% in the first quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider’s stock valued at $33,256,000 after purchasing an additional 2,950 shares during the last quarter. Finally, Circle Wealth Management LLC bought a new stake in shares of Humana in the first quarter worth $425,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

HUM has been the subject of a number of analyst reports. Sanford C. Bernstein raised their target price on shares of Humana from $269.00 to $341.00 and gave the company an “outperform” rating in a research report on Friday, September 5th. Guggenheim restated a “buy” rating on shares of Humana in a research note on Friday. Bank of America lifted their target price on Humana from $285.00 to $312.00 and gave the company a “neutral” rating in a research report on Tuesday, September 2nd. Mizuho set a $300.00 price target on Humana in a research report on Friday. Finally, Piper Sandler decreased their price target on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research note on Thursday, July 31st. Seven analysts have rated the stock with a Buy rating, thirteen have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $291.21.

Humana Trading Up 10.7%

Shares of Humana stock opened at $284.00 on Monday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The business has a fifty day simple moving average of $274.76 and a two-hundred day simple moving average of $257.29. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35. The company has a market capitalization of $34.16 billion, a price-to-earnings ratio of 21.80, a P/E/G ratio of 1.67 and a beta of 0.42.

Humana (NYSE:HUM) last issued its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). The company had revenue of $32.39 billion during the quarter, compared to the consensus estimate of $31.85 billion. Humana had a net margin of 1.28% and a return on equity of 13.67%. Humana’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the previous year, the company earned $6.96 earnings per share. Humana has set its FY 2025 guidance at 17.000- EPS. Research analysts forecast that Humana Inc. will post 16.47 EPS for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. The ex-dividend date is Friday, September 26th. Humana’s payout ratio is currently 27.17%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.